Letter to the Editor: The high cost of Rx drugs

Year after year, Americans pay the highest brand-name drug prices in the world. Congress, the Administration, and importantly, our own Delaware legislators must take action now to cut prescription drug prices.

I recently had some challenges with an eye drop medication that I need to treat my glaucoma. The drug company set the price so high, I can’t afford it even with Union and Medicare coverage.

That’s why AARP launched a national campaign urging federal and state policymakers to Stop Rx Greed by cracking down on price-gouging drug companies. AARP’s goal is to help lower drug prices for all Americans through decisive actions and solutions aimed not only at the federal level but also at the state level.

AARP is supporting the Prescription Drug Pricing Act, a bi-partisan bill that would cap out-of-pocket drug expenses for Medicare beneficiaries and require drug companies to pay a penalty if they raise prices higher than the rate of inflation.

Here in Delaware, the average annual cost of prescription drug treatment increased 58 percent between 2012 and 2017, while the annual income for Delawareans only increased 9 percent.

No American should be forced to choose between paying for the medicines they need and paying for food, rent, or other necessities. We urge Delaware lawmakers to work together with all members of Congress now to protect older Americans and pass bipartisan, commonsense legislation to lower prescription drug prices.

John Walsh,

Rehoboth Beach

AARP Advocate and Executive Council member

Facebook Comment